Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1988 Jan;35(1):63-82.
doi: 10.2165/00003495-198835010-00004.

GnRH agonists and antagonists. Current clinical status

M Filicori  1 , C Flamigni
Affiliations
Review

GnRH agonists and antagonists. Current clinical status

M Filicori et al. Drugs. 1988 Jan.

Abstract

Gonadotrophin-releasing hormone (GnRH) analogues offer a novel approach for the non-steroidal manipulation of the reproductive endocrine axis. GnRH agonists are now effectively employed in the management of precocious puberty, prostate and breast cancer, endometriosis, uterine leiomyoma, polycystic ovarian disease, and various other disorders. Unfortunately, contraceptive applications of GnRH agonists have been disappointing. The availability of slow release depot formulations of GnRH agonists, and the development of GnRH antagonists may further optimise and extend the clinical application of these compounds.

PubMed Disclaimer

References

    1. Endocr Rev. 1986 Feb;7(1):89-94 - PubMed
    1. J Clin Endocrinol Metab. 1981 Feb;52(2):370-2 - PubMed
    1. Endocr Rev. 1986 Feb;7(1):24-33 - PubMed
    1. Proc Natl Acad Sci U S A. 1982 Mar;79(5):1658-62 - PubMed
    1. J Clin Endocrinol Metab. 1988 Feb;66(2):327-33 - PubMed

MeSH terms

Substances

LinkOut - more resources